Opus Genetics, Inc. (IRD)
4.23
+0.03
(+0.71%)
USD |
NASDAQ |
Nov 10, 16:00
4.24
+0.01
(+0.24%)
After-Hours: 20:00
Opus Genetics Price : 4.23 for Nov. 10, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 10, 2026 | 4.18 | 4.270 | 4.03 | 4.23 | 1.071M |
| Nov 09, 2026 | 4.24 | 4.365 | 4.154 | 4.20 | 1.146M |
| Nov 06, 2026 | 4.02 | 4.24 | 4.01 | 4.18 | 784743.0 |
| Nov 05, 2026 | 4.26 | 4.26 | 3.79 | 4.005 | 1.474M |
| Nov 04, 2026 | 4.05 | 4.32 | 3.98 | 4.27 | 1.163M |
| Nov 03, 2026 | 3.74 | 3.99 | 3.74 | 3.93 | 1.130M |
| Nov 02, 2026 | 3.67 | 3.78 | 3.61 | 3.70 | 878199.0 |
| Oct 30, 2026 | 3.58 | 3.69 | 3.42 | 3.67 | 1.020M |
| Oct 29, 2026 | 3.68 | 3.82 | 3.60 | 3.65 | 709596.0 |
| Oct 28, 2026 | 3.44 | 3.69 | 3.40 | 3.68 | 1.033M |
| Oct 27, 2026 | 3.32 | 3.53 | 3.28 | 3.46 | 1.304M |
| Oct 26, 2026 | 3.49 | 3.50 | 3.23 | 3.32 | 1.520M |
| Oct 23, 2026 | 3.79 | 3.83 | 3.44 | 3.47 | 1.118M |
| Oct 22, 2026 | 4.04 | 4.10 | 3.80 | 3.82 | 894737.0 |
| Oct 21, 2026 | 4.03 | 4.215 | 4.00 | 4.115 | 1.356M |
| Oct 20, 2026 | 3.82 | 4.145 | 3.78 | 4.01 | 1.461M |
| Oct 19, 2026 | 3.87 | 3.940 | 3.69 | 3.82 | 1.528M |
| Oct 16, 2026 | 4.12 | 4.13 | 3.75 | 3.84 | 2.532M |
| Oct 15, 2026 | 4.15 | 4.280 | 3.975 | 4.05 | 2.953M |
| Oct 14, 2026 | 4.395 | 4.395 | 4.08 | 4.10 | 1.200M |
| Oct 13, 2026 | 4.76 | 4.77 | 4.23 | 4.24 | 1.294M |
| Oct 12, 2026 | 4.63 | 4.88 | 4.60 | 4.64 | 1.624M |
| Oct 09, 2026 | 4.46 | 4.74 | 4.45 | 4.65 | 1.257M |
| Oct 08, 2026 | 4.41 | 4.48 | 4.245 | 4.46 | 1.346M |
| Oct 07, 2026 | 4.35 | 4.66 | 4.25 | 4.41 | 1.841M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Rezolute, Inc. | 4.02 |
| Faeth Therapeutics, Inc. | 12.92 |
| Nuvectis Pharma, Inc. | 21.08 |
| ACADIA Pharmaceuticals, Inc. | 18.28 |
| Alnylam Pharmaceuticals, Inc. | 151.64 |
Price Related Metrics
| PS Ratio | 49.44 |
| Price to Book Value | 10.54 |
| Earnings Yield | -37.50% |
| Market Cap | 349.60M |